Skip to main content Back to Top
Advertisement

11/29/2021

Magnesium Sulfate Injection

Products Affected - Description

    • Magnesium sulfate intravenous injection, Fresenius Kabi, 500 mg/mL, 2 mL vial, 25 count, NDC 63323-0064-03
    • Magnesium sulfate intravenous injection, Fresenius Kabi, 500 mg/mL, 20 mL vial, 25 count, NDC 63323-0642-20
    • Magnesium sulfate intravenous injection, Fresenius Kabi, 500 mg/mL, 50 mL vial, 25 count, NDC 63323-0642-50
    • Magnesium sulfate intravenous injection, Pfizer, 500 mg/mL, 20 mL vial, 25 count, NDC 00409-2168-77
    • Magnesium sulfate intravenous injection, Pfizer, 10 mg/mL, 100 mL premixed bag, 24 count, NDC 00409-6727-23
    • Magnesium sulfate intravenous injection, Pfizer, 40 mg/mL, 50 mL premixed bag, 24 count, NDC 00409-6729-24

Reason for the Shortage

    • American Regent is not currently marketing magnesium sulfate which has been unavailable since late 2012.
    • Baxter has magnesium sulfate injection available.
    • BBraun has magnesium injection available.
    • Exela launched magnesium sulfate vials in May 2018.
    • Fresenius Kabi had magnesium sulfate injection on shortage due to increased demand for the product.
    • Sagent has magnesium sulfate injection available.
    • Pfizer had magnesium sulfate injection on shortage due to increased demand. The 500 mg/mL 20 mL vials were discontinued in August 2020.
    • WG Critical Care has magnesium sulfate injection available.
    • X-Gen discontinued magnesium sulfate in April 2018.

Available Products

    • Magnesium sulfate intravenous injection, Exela Pharma Sciences, 500 mg/mL, 10 mL vial, 25 count, NDC 51754-1000-04
    • Magnesium sulfate intravenous injection, Fresenius Kabi, 500 mg/mL, 10 mL vial, 25 count, NDC 63323-0064-11
    • Magnesium sulfate intravenous injection, Pfizer, 500 mg/mL, 10 mL syringe, 10 count, NDC 00409-1754-10
    • Magnesium sulfate intravenous injection, BBraun, 10 mg/mL, 100 mL premixed bag, 24 count, NDC 00264-4400-54
    • Magnesium sulfate intravenous injection, Baxter, 10 mg/mL, 100 mL premixed bag, 40 count, NDC 00338-1709-40
    • Magnesium sulfate intravenous injection, Fresenius Kabi, 10 mg/mL, 100 mL premixed bag, 24 count, NDC 63323-0108-01
    • Magnesium sulfate intravenous injection, WG Critical Care, 10 mg/mL, 100 mL premixed bag, 24 count, NDC 44567-0410-24
    • Magnesium sulfate intravenous injection, BBraun, 40 mg/mL, 100 mL premixed bag, 24 count, NDC 00264-4206-54
    • Magnesium sulfate intravenous injection, BBraun, 40 mg/mL, 50 mL premixed bag, 24 count, NDC 00264-4204-52
    • Magnesium sulfate intravenous injection, BBraun, 80 mg/mL, 50 mL premixed bag, 24 count, NDC 00264-4205-52
    • Magnesium sulfate intravenous injection, Baxter, 40 mg/mL, 100 mL premixed bag, 40 count, NDC 00338-1719-40
    • Magnesium sulfate intravenous injection, Baxter, 40 mg/mL, 50 mL premixed bag, 40 count, NDC 00338-1708-40
    • Magnesium sulfate intravenous injection, Baxter, 80 mg/mL, 50 mL premixed bag, 40 count, NDC 00338-1715-40
    • Magnesium sulfate intravenous injection, Fresenius Kabi, 40 mg/mL, 100 mL premixed bag, 24 count, NDC 63323-0106-01
    • Magnesium sulfate intravenous injection, Fresenius Kabi, 40 mg/mL, 1000 mL premixed bag, 24 count, NDC 63323-0106-10
    • Magnesium sulfate intravenous injection, Fresenius Kabi, 40 mg/mL, 50 mL premixed bag, 24 count, NDC 63323-0106-05
    • Magnesium sulfate intravenous injection, Fresenius Kabi, 40 mg/mL, 500 mL premixed bag, 24 count, NDC 63323-0106-15
    • Magnesium sulfate intravenous injection, Fresenius Kabi, 80 mg/mL, 50 mL premixed bag, 24 count, NDC 63323-0107-05
    • Magnesium sulfate intravenous injection, Pfizer, 40 mg/mL, 100 mL premixed bag, 24 count, NDC 00409-6729-23
    • Magnesium sulfate intravenous injection, Pfizer, 40 mg/mL, 1000 mL premixed bag, 24 count, NDC 00409-6729-09
    • Magnesium sulfate intravenous injection, Pfizer, 40 mg/mL, 500 mL premixed bag, 24 count, NDC 00409-6729-03
    • Magnesium sulfate intravenous injection, Pfizer, 80 mg/mL, 50 mL premixed bag, 24 count, NDC 00409-6730-13
    • Magnesium sulfate intravenous injection, Sagent, 40 mg/mL, 100 mL premixed bag, 10 count, NDC 25021-0612-82
    • Magnesium sulfate intravenous injection, Sagent, 40 mg/mL, 50 mL premixed bag, 10 count, NDC 25021-0612-81
    • Magnesium sulfate intravenous injection, WG Critical Care, 40 mg/mL, 100 mL premixed bag, 24 count, NDC 44567-0421-24
    • Magnesium sulfate intravenous injection, WG Critical Care, 40 mg/mL, 50 mL premixed bag, 24 count, NDC 44567-0420-24

Estimated Resupply Dates

    • Exela has 500 mg/mL 10 mL vials available for direct orders only.
    • Fresenius Kabi has magnesium sulfate 500 mg/mL 2 mL vials on back order and the company estimates a release date of late-December 2021. The 500 mg/mL 20 mL and 50 mL vials are on back order and the company estimates a release date of mid- to late-January 2022 for the 20 mL vials and late-December 2021 for the 50 mL vials.
    • Pfizer has magnesium sulfate 500 mg/mL 20 mL vials on back order and the company estimates a release date of December 2021. The 10 mg/mL 100 mL premixed bags are on back order and the company estimates a release date of December 2021. The 40 mg/mL 50 mL premixed bags are available in limited supply.

Updated

Updated November 29, 2021 by Michelle Wheeler, PharmD, Drug Information Specialist. Created March 30, 2011 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2021, Drug Information Service, University of Utah, Salt Lake City, UT.

ADVERTISEMENT

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.